» Articles » PMID: 28706405

Vulvar Lichen Sclerosus Et Atrophicus

Overview
Date 2017 Jul 15
PMID 28706405
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Vulvar lichen sclerosus (VLS) is a chronic inflammatory dermatosis characterized by ivory-white plaques or patches with glistening surface commonly affecting the vulva and anus. Common symptoms are irritation, soreness, dyspareunia, dysuria, and urinary or fecal incontinence. Anogenital lichen sclerosus (LS) is characterized by porcelain-white atrophic plaques, which may become confluent extending around the vulval and perianal skin in a figure of eight configuration. Thinning and shrinkage of the genital area make coitus, urination, and defecation painful. LS is not uncommon in India and present as an itchy vulvar dermatosis which a gynecologist may mistake for candidal vulvovaginitis. There is often a delay in diagnosis of VLS due to its asymptomatic nature and lack of awareness in patients as well as physicians. Embarrassment of patients due to private nature of the disease and failure to examine the genital skin properly are the other reasons for delay in diagnosis. There is no curative treatment for LS. Various medications available only relieve the symptoms. Chronic nature of the disease affects the quality of life. Proper and regular follow-up is required as there are chances of the development of squamous cell carcinoma.

Citing Articles

Successful Microablative Fractional Carbon Dioxide Laser Therapy for Vulvar Lichen Sclerosus: A Case Report and Mini-review.

Hsieh W, Ding D Gynecol Minim Invasive Ther. 2024; 13(4):272-275.

PMID: 39660244 PMC: 11626895. DOI: 10.4103/gmit.gmit_71_24.


Development and Validation of a Machine Learning-Based Early Warning Model for Lichenoid Vulvar Disease: Prediction Model Development Study.

Meng J, Niu X, Luo C, Chen Y, Li Q, Wei D J Med Internet Res. 2024; 26:e55734.

PMID: 39576990 PMC: 11624445. DOI: 10.2196/55734.


Barriers to diagnosing and treating vulval lichen sclerosus: a survey study.

Crew A, Leatherland R, Clarke L, Owen C, Simpson R, Simpson R Br J Gen Pract. 2024; .

PMID: 39516015 PMC: 11881009. DOI: 10.3399/BJGP.2024.0360.


Lichen Sclerosus-Incidence and Comorbidity: A Nationwide Swedish Register Study.

Jerkovic Gulin S, Lundin F, Eriksson O, Seifert O J Clin Med. 2024; 13(10).

PMID: 38792303 PMC: 11122656. DOI: 10.3390/jcm13102761.


Aesthetic Gynaecology: What Women Want?.

Mohammad S, Joshi K, Mohammad S, Acharya N Cureus. 2023; 15(8):e44251.

PMID: 37772220 PMC: 10523831. DOI: 10.7759/cureus.44251.


References
1.
Penneys N . Treatment of lichen sclerosus with potassium para-aminobenzoate. J Am Acad Dermatol. 1984; 10(6):1039-42. DOI: 10.1016/s0190-9622(84)80332-1. View

2.
Soini Y, Paakko P, Vahakangas K, Vuopala S, Lehto V . Expression of p53 and proliferating cell nuclear antigen in lichen sclerosus et atrophicus with different histological features. Int J Gynecol Pathol. 1994; 13(3):199-204. DOI: 10.1097/00004347-199407000-00002. View

3.
Sotiriou E, Panagiotidou D, Ioannidis D . An open trial of 5-aminolevulinic acid photodynamic therapy for vulvar lichen sclerosus. Eur J Obstet Gynecol Reprod Biol. 2008; 141(2):187-8. DOI: 10.1016/j.ejogrb.2008.07.027. View

4.
Cox N, Mitchell J, Morley W . Lichen sclerosus et atrophicus in non-identical female twins. Br J Dermatol. 1986; 115(6):743. DOI: 10.1111/j.1365-2133.1986.tb06659.x. View

5.
Zawislak A, McCluggage W, Donnelly R, Maxwell P, Price J, Dobbs S . Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system. Photodermatol Photoimmunol Photomed. 2009; 25(2):111-3. DOI: 10.1111/j.1600-0781.2009.00410.x. View